Phase 2 Bipolar Disorder Trial, Recruiting (NCT07399626)

Phase 2 Bipolar Disorder Trial, Recruiting NCT07399626 Sponsor: Babes-Bolyai University Condition: Bipolar Disorder

Printed from Voxsanity (voxsanity.com.au) — NCT07399626 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Bipolar Disorder

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are between 18 and 50 years old
People who are not currently considered at high risk of suicide
People who do not currently have a serious substance use disorder or alcohol use disorder
People whose native language is Romanian
People who have the cognitive ability to read and understand written questions

Who may not be able to join:

People who are currently considered to be at high risk of suicide
People who currently have a serious substance use disorder or alcohol use disorder

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: Romania: 0731 739 485

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07399626

Sponsor: Babes-Bolyai University

Phase: Phase 2

Status: Recruiting

Condition: Bipolar Disorder

Trial contact: Romania: 0731 739 485

More information: https://clinicaltrials.gov/study/NCT07399626

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are between 18 and 50 years old
People who are not currently considered at high risk of suicide
People who do not currently have a serious substance use disorder or alcohol use disorder
People whose native language is Romanian
People who have the cognitive ability to read and understand written questions

Who may not be able to join:

People who are currently considered to be at high risk of suicide
People who currently have a serious substance use disorder or alcohol use disorder

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 2

Sponsor

Babes-Bolyai University

Registry

ClinicalTrials.gov

Start date

22 September 2025

Est. completion

1 May 2026

Where this trial is recruiting

🇷🇴 Romania

Primary endpoints

Hypomanic Personality Scale - 6 (HPS-6); Mood Disorder Questionnaire (MDQ); Behavioral Inhibition System / Behavioral Activation System scales (BISBAS); Positive and Negative Affect Schedule (PANAS); Negative Urgency, Premeditation, Perseverance, Sensations Seeking, and Positive Urgency - Impulsive Behavior Scale (UPPS-P); Affective Lability Scale - Short Form (ALS-18); Positive Overgeneralization (POG); Altman Self-Rating Mania Scale (ASRM); Food Neophobia Scale (FNS); Patient Health Questionnaire-9 (PHQ-9); Importance of Olfaction (IOS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov